comparemela.com

Latest Breaking News On - Theralink technologies - Page 5 : comparemela.com

Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger

Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.

Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay for.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.